NO327924B1 - Benzofuranderivater, deres fremstilling og anvendelse samt preparater inneholdende nevnte derivater - Google Patents

Benzofuranderivater, deres fremstilling og anvendelse samt preparater inneholdende nevnte derivater Download PDF

Info

Publication number
NO327924B1
NO327924B1 NO20012726A NO20012726A NO327924B1 NO 327924 B1 NO327924 B1 NO 327924B1 NO 20012726 A NO20012726 A NO 20012726A NO 20012726 A NO20012726 A NO 20012726A NO 327924 B1 NO327924 B1 NO 327924B1
Authority
NO
Norway
Prior art keywords
compound
dihydro
benzofuran
pentamethyl
salt
Prior art date
Application number
NO20012726A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012726D0 (no
NO20012726L (no
Inventor
Shigenori Ohkawa
Yasuyoshi Arikawa
Kouki Kato
Masahiro Okura
Masaki Setoh
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NO20012726D0 publication Critical patent/NO20012726D0/no
Publication of NO20012726L publication Critical patent/NO20012726L/no
Publication of NO327924B1 publication Critical patent/NO327924B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Seasonings (AREA)
NO20012726A 1998-12-04 2001-06-01 Benzofuranderivater, deres fremstilling og anvendelse samt preparater inneholdende nevnte derivater NO327924B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34536598 1998-12-04
JP34535598 1998-12-04
PCT/JP1999/006764 WO2000034262A1 (fr) 1998-12-04 1999-12-02 Derives de benzofuranne, leur procede de preparation et leurs utilisations

Publications (3)

Publication Number Publication Date
NO20012726D0 NO20012726D0 (no) 2001-06-01
NO20012726L NO20012726L (no) 2001-07-31
NO327924B1 true NO327924B1 (no) 2009-10-19

Family

ID=26578009

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012726A NO327924B1 (no) 1998-12-04 2001-06-01 Benzofuranderivater, deres fremstilling og anvendelse samt preparater inneholdende nevnte derivater

Country Status (14)

Country Link
US (3) US6479536B1 (fr)
EP (1) EP1136477B1 (fr)
JP (1) JP4778570B2 (fr)
KR (1) KR100660788B1 (fr)
CN (1) CN1297550C (fr)
AT (1) ATE261435T1 (fr)
AU (1) AU1414600A (fr)
CA (1) CA2352786C (fr)
DE (1) DE69915508T2 (fr)
ES (1) ES2213407T3 (fr)
HU (1) HU226652B1 (fr)
NO (1) NO327924B1 (fr)
PT (1) PT1136477E (fr)
WO (1) WO2000034262A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1297550C (zh) * 1998-12-04 2007-01-31 武田药品工业株式会社 苯并呋喃衍生物及其制备和用途
ES2317935T3 (es) * 2000-10-05 2009-05-01 Takeda Pharmaceutical Company Limited Promotores de la proliferacion y diferenciacion de celulas pluripotenciales y/o celulas precursoras neuronales.
CA2432410A1 (fr) 2000-12-28 2002-07-11 Takeda Chemical Industries, Ltd. Procede de preparation de composes a base de 2,3-dihydrobenzofurane a activite optique
EP1411052B1 (fr) 2001-07-05 2011-10-05 Takeda Pharmaceutical Company Limited Composes heterocycles a 5 chainons condenses avec un benzo, leur procede de preparation et leur utilisation
ATE406357T1 (de) * 2001-07-13 2008-09-15 Takeda Pharmaceutical Verfahren zur herstellung von benzofuranderivaten
US20050118202A1 (en) * 2001-12-19 2005-06-02 Akio Yamashita Solid compositions containing compounds unstable to oxygen and method for stabilization thereof
US6653346B1 (en) * 2002-02-07 2003-11-25 Galileo Pharmaceuticals, Inc. Cytoprotective benzofuran derivatives
US7078541B2 (en) * 2002-02-07 2006-07-18 Galileo Pharmaceuticals, Inc. Benzofuran derivatives
JP4537011B2 (ja) * 2002-03-01 2010-09-01 武田薬品工業株式会社 抗うつ剤
US20050148650A1 (en) 2002-03-01 2005-07-07 Shigenori Ohkawa Antidepressant
NZ544298A (en) * 2003-06-26 2009-04-30 Takeda Pharmaceutical Cannabinoid receptor modulators including benzofuran derivatives
EP1589016A1 (fr) * 2004-04-13 2005-10-26 Cephalon France Dérivés tricycliques et bicycliques aromatiques de méthansulfinyle, substitués par THIO
US7119214B2 (en) 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
DE602005019562D1 (de) * 2004-05-05 2010-04-08 Hoffmann La Roche Zur modulation des 5-ht6-rezeptors, des 5-ht2a-rezeptors oder beider rezeptoren geeignete arylsulfonylbenzodioxane
EP1783121A4 (fr) * 2004-08-27 2009-08-05 Takeda Pharmaceutical Composés azoïques, procédé de production de ceux-ci
US20060125084A1 (en) * 2004-12-15 2006-06-15 Fazzio Ronald S Integration of micro-electro mechanical systems and active circuitry
WO2006066756A1 (fr) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Derives de chromane utiles dans le traitement des troubles du systeme nerveux central
SI1831159T1 (sl) * 2004-12-21 2010-04-30 Hoffmann La Roche Derivati tetralina in indana ter njune uporabe
JP2008524275A (ja) * 2004-12-21 2008-07-10 エフ．ホフマン−ラ ロシュ アーゲー クロマン誘導体及び５−ｈｔレセプターリガンドとしてのそれらの使用
EP1831152B1 (fr) * 2004-12-21 2008-09-24 F. Hoffmann-La Roche AG Derives de tetraline et d'indane et utilisations de ceux-ci en tant qu'antagonistes de la 5-ht
CA2591793A1 (fr) * 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Derives de tetraline et d'indane, et utilisations de ceux-ci
PE20070077A1 (es) * 2005-06-10 2007-02-07 Takeda Pharmaceutical Comprimido con recubierta con azucar
KR100984897B1 (ko) * 2005-11-03 2010-10-01 에프. 호프만-라 로슈 아게 5-ｈｔ6 억제제로서 아릴설포닐 크로만
WO2007069693A1 (fr) 2005-12-15 2007-06-21 Seikagaku Corporation Longue chaine de sucre de chondroitine et son procede de production et procede favorisant la synthese de la chondroitine
JP2009541248A (ja) * 2006-06-20 2009-11-26 エフ．ホフマン−ラ ロシュ アーゲー アリールスルホンアミジルテトラリン誘導体及びそれらの使用
JP2009541249A (ja) * 2006-06-20 2009-11-26 エフ．ホフマン−ラ ロシュ アーゲー アリールスルホニルナフタレン誘導体およびその使用
JP2009541252A (ja) * 2006-06-20 2009-11-26 エフ．ホフマン−ラ ロシュ アーゲー テトラリン及びインダン誘導体ならびにそれらの使用
AR063618A1 (es) * 2006-11-09 2009-02-04 Takeda Pharmaceutical Composicion farmaceutica
ES2487616T3 (es) 2009-03-10 2014-08-22 Takeda Pharmaceutical Company Limited Derivados de benzofurano
WO2011062194A1 (fr) 2009-11-18 2011-05-26 武田薬品工業株式会社 Dérivé d'aminopyridine
CN102712853B (zh) 2009-12-24 2014-12-24 Scg化学有限公司 用于减小烃的溴指数的方法
CN105294662B (zh) * 2015-09-11 2018-04-20 中山大学 苯并呋喃喹啉衍生物及其在制备治疗阿尔茨海默病症的药品中的应用
CN115260136B (zh) * 2022-08-09 2023-08-15 嘉兴学院 一种苯酞类化合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU163046B (fr) 1970-08-25 1973-05-28
US4212865A (en) 1978-12-26 1980-07-15 Riker Laboratories, Inc. Amine derivatives of 2-nitro-3-phenylbenzofuran
US4881967A (en) 1986-12-10 1989-11-21 E. I. Du Pont De Nemours And Company Heterocyclic 2,3-dihydrobenzofuran herbicides
TW199152B (fr) 1990-11-01 1993-02-01 Takeda Pharm Industry Co Ltd
EP0632031B1 (fr) 1990-12-28 2000-05-03 Teijin Limited Compose cyclique condense de benzoxa, son procede de production, et composition pharmaceutique le contenant
EP0539709A1 (fr) * 1991-09-18 1993-05-05 FUJIREBIO Inc. Dérivés de l'acide 3,5-dihydroxyheptanoique et leurs lactones comme inhibiteurs d'HMG-CoA réductase
JP3168728B2 (ja) * 1991-09-18 2001-05-21 富士レビオ株式会社 ３，５−ジヒドロキシヘプタン酸誘導体
GB9408577D0 (en) 1994-04-29 1994-06-22 Fujisawa Pharmaceutical Co New compound
DE69507197T2 (de) * 1994-05-31 1999-05-27 Bayer Ag, 51373 Leverkusen Aminobenzofuryl- und -thienylderivate
GB9522007D0 (en) * 1995-10-27 1996-01-03 Fujisawa Pharmaceutical Co New compound
WO1998008842A1 (fr) 1996-08-29 1998-03-05 Takeda Chemical Industries, Ltd. Composes ether cyclique utilises en tant que modulateurs des canaux sodiques
WO1998055454A2 (fr) 1997-06-05 1998-12-10 Takeda Chemical Industries, Ltd. Composes heterocycliques, leur preparation et leur utilisation
CN1297550C (zh) * 1998-12-04 2007-01-31 武田药品工业株式会社 苯并呋喃衍生物及其制备和用途

Also Published As

Publication number Publication date
US20050187238A1 (en) 2005-08-25
NO20012726D0 (no) 2001-06-01
WO2000034262A1 (fr) 2000-06-15
KR100660788B1 (ko) 2007-02-28
HUP0105480A3 (en) 2003-07-28
JP4778570B2 (ja) 2011-09-21
EP1136477B1 (fr) 2004-03-10
CN1297550C (zh) 2007-01-31
KR20010081113A (ko) 2001-08-27
US20020160996A1 (en) 2002-10-31
CN1333764A (zh) 2002-01-30
CA2352786C (fr) 2009-02-03
US7456162B2 (en) 2008-11-25
AU1414600A (en) 2000-06-26
US6479536B1 (en) 2002-11-12
ES2213407T3 (es) 2004-08-16
EP1136477A4 (fr) 2002-04-10
HUP0105480A2 (hu) 2002-11-28
DE69915508D1 (de) 2004-04-15
PT1136477E (pt) 2004-08-31
NO20012726L (no) 2001-07-31
HU226652B1 (en) 2009-05-28
EP1136477A1 (fr) 2001-09-26
JP2009185049A (ja) 2009-08-20
ATE261435T1 (de) 2004-03-15
US7101867B2 (en) 2006-09-05
DE69915508T2 (de) 2005-01-27
CA2352786A1 (fr) 2000-06-15

Similar Documents

Publication Publication Date Title
NO327924B1 (no) Benzofuranderivater, deres fremstilling og anvendelse samt preparater inneholdende nevnte derivater
EP3087067B1 (fr) Composés 4-(pipérazin-1-yl)-pyrrolidin-2-one comme inhibiteurs de la monoacylglycérol lipase (magl)
US20070149558A1 (en) Benzo-fused 5-membered heterocyclic compounds, their production and use
TWI477497B (zh) 苯并呋喃衍生物
US7884127B2 (en) Inhibitors of cyclin dependent kinases and their use
EA004704B1 (ru) Производные феноксипропиламина
US20090012081A1 (en) Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells
JP4357802B2 (ja) ベンゼン環縮合５員複素環式化合物、その製造法および用途
KR100470692B1 (ko) 시아노-인돌 세로토닌 재흡수 억제 화합물, 이의 제조방법 및 이를 함유하는 약제 조성물
WO2006036031A1 (fr) Dérivé polycyclique du furanne et utilisation dudit dérivé
JPH1149765A (ja) 複素環化合物、その製造法および剤
JP3553442B2 (ja) ベンゾフラン誘導体、その製造法および用途
JP4364467B2 (ja) ベンゾフラン誘導体、その製造法および用途
JP2002348239A (ja) 幹細胞・神経前駆細胞の増殖・分化促進剤
WO2013168760A1 (fr) Composé cyclique aromatique
TWI454473B (zh) 稠環化合物及其用途
WO2020224396A1 (fr) Composés inhibant l'activité de tdg
JPH11310532A (ja) 熱産生促進剤
JP2001131179A (ja) 三環性ジヒドロフラン誘導体、その製造法及び剤
HU189679B (en) Process for producing condensed pyrrolinone derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees